Which clinical trial phase primarily assesses efficacy in patients?

Prepare for the Drug Discovery and Healthcare Systems Test. Access flashcards and multiple-choice questions with hints and explanations. Ace your exam with our comprehensive resources!

Multiple Choice

Which clinical trial phase primarily assesses efficacy in patients?

Efficacy in patients is evaluated in Phase II. In this stage, the treatment is given to people who have the disease to see if it produces the intended therapeutic effect at selected dose levels, while still collecting information on safety and side effects. Phase I is mainly about safety, tolerability, and how the drug is processed in the body—often in a small group or, sometimes, in healthy volunteers. Phase III involves large-scale trials to confirm efficacy and safety, usually comparing the new treatment to the current standard of care. Phase IV occurs after approval, continuing to monitor long-term safety and real-world effectiveness. The reason Phase II is the best answer is that its purpose is to establish whether the drug works in patients, at the explored doses, based on observed treatment effects.

Efficacy in patients is evaluated in Phase II. In this stage, the treatment is given to people who have the disease to see if it produces the intended therapeutic effect at selected dose levels, while still collecting information on safety and side effects. Phase I is mainly about safety, tolerability, and how the drug is processed in the body—often in a small group or, sometimes, in healthy volunteers. Phase III involves large-scale trials to confirm efficacy and safety, usually comparing the new treatment to the current standard of care. Phase IV occurs after approval, continuing to monitor long-term safety and real-world effectiveness. The reason Phase II is the best answer is that its purpose is to establish whether the drug works in patients, at the explored doses, based on observed treatment effects.

More practice questions